269 related articles for article (PubMed ID: 17711900)
1. Infant perinatal thrombosis and antiphospholipid antibodies: a review.
Boffa MC; Lachassinne E
Lupus; 2007; 16(8):634-41. PubMed ID: 17711900
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
[TBL] [Abstract][Full Text] [Related]
4. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
Deeb A; Hamdoun S; Dababo K
Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789
[TBL] [Abstract][Full Text] [Related]
6. Interpretation and recommended testing for antiphospholipid antibodies.
Galli M
Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
[TBL] [Abstract][Full Text] [Related]
7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
8. [Ischemic stroke with antiphospholipid antibody].
Kitagawa Y; Ohkuma H; Tokuoka K
Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of antiphospholipid antibodies (aPL) in patients with cerebrovascular disease.
Gonzales-Portillo F; McIntyre JA; Wagenknecht DR; Williams LS; Bruno A; Biller J
J Stroke Cerebrovasc Dis; 2001; 10(5):222-6. PubMed ID: 17903828
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
11. Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations.
Favaloro EJ; Reben R; Mohammed S; Koutts J
Intern Med J; 2012 Apr; 42(4):427-34. PubMed ID: 20681961
[TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: Report of a family with multiple anti-phospholipid positive members.
De Angelis V; Scurati S; Raschi E; Liutkus A; Belot A; Borghi MO; Meroni PL; Cimaz R
J Autoimmun; 2009 Feb; 32(1):60-3. PubMed ID: 19108989
[TBL] [Abstract][Full Text] [Related]
13. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies.
Khamashta MA
J Autoimmun; 2000 Sep; 15(2):249-53. PubMed ID: 10968919
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Avcin T; Silverman ED
Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the 2006 revised antiphospholipid syndrome classification criteria.
Kaul M; Erkan D; Sammaritano L; Lockshin MD
Ann Rheum Dis; 2007 Jul; 66(7):927-30. PubMed ID: 17337473
[TBL] [Abstract][Full Text] [Related]
17. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
18. [Neurological aspects in antiphospholipid syndrome].
Kitagawa Y
Rinsho Shinkeigaku; 2003 Nov; 43(11):744-7. PubMed ID: 15152454
[TBL] [Abstract][Full Text] [Related]
19. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study.
Ruffatti A; Del Ross T; Ciprian M; Nuzzo M; Rampudda M; Bertero MT; Bergia R; Caramaschi P; Biasi D; Capsoni F; Montaguti L; Ruffini R; Brucato A; Picillo U; Fanelli V; Riccieri V; Piccoli A; Valesini G; Doria A; Meroni PL; Tincani A
Ann Rheum Dis; 2009 Mar; 68(3):397-9. PubMed ID: 18812393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
